Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01246466 · ClinicalTrials.gov registry record · NA
Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01246466 is a NA study that has completed, run by AtriCure. The registered enrollment target is 24 participants.
The verdict
NCT01246466, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and how effective this combined procedure is using the AtriCure System in treating AF. The AtriCure Bipolar System will be used to perform the less invasive cardiac surgery and a standard electrophysiology catheter, currently available, will be used to perform the catheter ablation procedure. This surgical procedure is considered less invasive because it is done through tiny surgical punctures on the sides of the chest near the ribs instead of one large surgical incision of the breast bone to completely open the chest and access the heart, and it also avoids the need for the heart-lung bypass machine.
Interventions
- DEVICE Hybrid: AtriCure Bipolar System & EP ablation procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01246466
The ClinicalTrials.gov registry entry for NCT01246466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hybrid: AtriCure Bipolar System & EP ablation procedure is the first listed.
NCT01246466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01246466 about?
NCT01246466 is a clinical study titled "Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study". The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and how effective this combined procedure is using the AtriCure System in treating AF. The AtriCure Bipo...
What is the current status of trial NCT01246466?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-12. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01246466?
The interventions under investigation include: Hybrid: AtriCure Bipolar System & EP ablation procedure (DEVICE).
Who is sponsoring clinical trial NCT01246466?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.